Reticulophagy regulator 1 (RETEG1, also known as FAM134B) plays a crucial role in endoplasmic reticulum autophagy. We aimed to explore the effect of FAM134B-mediated endoplasmic reticulum autophagy in
sepsis myocardial injury in mice.
Sepsis myocardial injury mice were established via cecal
ligation and
puncture procedures. The expression of FAM134B and LC3-II/I was determined using immunohistochemistry. Myocardial tissue morphological changes and apoptosis were examined using
hematoxylin and
eosin (H&E) staining and TUNEL analysis. The effects of FAM134B knockdown or overexpression on mice with
sepsis myocardial injury were also studied. The levels of TNF-α,
IL-6,
IL-8, and
IL-10 were evaluated using
enzyme-linked
immunosorbent assay (ELISA). Autophagy- and apoptosis-related
protein expression was detected using western blotting. The effect of FAM134B on
Lipopolysaccharide (LPS) -induced cardiomyocytes was also studied. The expression of FAM134B and LC3-II/I increased in
sepsis mice and
lipopolysaccharide (LPS)-treated cardiomyocytes.
3-Methyladenine (3-MA) significantly inhibited FAM134B and LC3-II/I expression and promoted myocardial injury,
inflammation response, and cardiomyocyte apoptosis. The overexpression of FAM134B could minimize myocardial injury,
inflammation, and apoptosis, whereas FAM134B knockdown showed opposite effects. FAM134B-mediated endoplasmic reticulum autophagy had a protective effect on
sepsis myocardial injury in mice by reducing
inflammation and tissue apoptosis, which may provide new insights for
sepsis myocardial injury
therapies.